At a glance
- Originator Nonindustrial source
- Class Antiarrhythmics; Small molecules
- Mechanism of Action Beta 1 adrenergic receptor antagonists; Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Heart failure
Most Recent Events
- 17 Nov 2003 Discontinued - Preclinical for Arrhythmias in India (unspecified route)
- 17 Nov 2003 Discontinued - Preclinical for Heart failure in India (unspecified route)
- 26 Sep 1997 Preclinical development for Heart failure in India (Unknown route)